Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.15 EUR | 0.00% | +1.32% | -30.51% |
May. 27 | Ulisse Biomed, agreement with Elettrobiochimica for IVDR kit development | AN |
May. 20 | Ulisse Biomed S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 9
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Diagnostic Kits
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -49.96% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Italy
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -49.96% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bruna Marini
FOU | Founder | 39 | - |
Rudy Ippodrino
FOU | Founder | - | - |
Matteo Petti
CEO | Chief Executive Officer | 41 | - |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Luigi Colombo
BRD | Director/Board Member | 60 | - |
Matteo Petti
CEO | Chief Executive Officer | 41 | - |
Laura Amadesi
BRD | Director/Board Member | 56 | - |
Saverio Scelzo
CHM | Chairman | 68 | - |
Bruna Marini
FOU | Founder | 39 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,804,769 | 20,256,360 ( 92.90 %) | 0 | 92.90 % |
Company contact information
Sector
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.51% | 27.19M | |
+55.20% | 58.06B | |
-3.58% | 40.53B | |
+36.87% | 38.99B | |
+14.58% | 26.7B | |
-12.01% | 26.56B | |
-21.64% | 18.98B | |
+0.14% | 12.17B | |
+23.87% | 12B | |
+26.63% | 11.92B |
- Stock Market
- Equities
- UBM Stock
- Company Ulisse Biomed S.p.A.